AstraZeneca (NYSE:AZN) plans to invest $630M in South Korea’s health-are sector over the next five years, Chairman Leif Johansson said in Stockholm at the Korea Sweden Business Summit.
via Bloomberg’s Amanda Billner.
AZN is also preparing to announce partnerships with health-care organizations in the country, he said.
The investment is intended to fund biomedical innovation, improve health-care access, and provide high-quality employment in South Korea.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.